Copyright Reports & Markets. All rights reserved.

Global Heparin (Low Molecular Weight) Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Heparin (Low Molecular Weight) Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Heparin (Low Molecular Weight) Market Size Growth Rate by Product
      • 1.4.2 Enoxaparin
      • 1.4.3 Dalteparin
      • 1.4.4 Tinzaparin
      • 1.4.5 Fraxiparine
    • 1.5 Market by End User
      • 1.5.1 Global Heparin (Low Molecular Weight) Market Size Growth Rate by End User
      • 1.5.2 Treatment of Venous Thromboembolism
      • 1.5.3 Complications of Pregnancy
      • 1.5.4 Cardioversion of Atrial Fibrillation/Flutter
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Heparin (Low Molecular Weight) Market Size
      • 2.1.1 Global Heparin (Low Molecular Weight) Revenue 2014-2025
      • 2.1.2 Global Heparin (Low Molecular Weight) Sales 2014-2025
    • 2.2 Heparin (Low Molecular Weight) Growth Rate by Regions
      • 2.2.1 Global Heparin (Low Molecular Weight) Sales by Regions
      • 2.2.2 Global Heparin (Low Molecular Weight) Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Heparin (Low Molecular Weight) Sales by Manufacturers
      • 3.1.1 Heparin (Low Molecular Weight) Sales by Manufacturers
      • 3.1.2 Heparin (Low Molecular Weight) Sales Market Share by Manufacturers
      • 3.1.3 Global Heparin (Low Molecular Weight) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Heparin (Low Molecular Weight) Revenue by Manufacturers
      • 3.2.1 Heparin (Low Molecular Weight) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Heparin (Low Molecular Weight) Revenue Share by Manufacturers (2014-2019)
    • 3.3 Heparin (Low Molecular Weight) Price by Manufacturers
    • 3.4 Heparin (Low Molecular Weight) Manufacturing Base Distribution, Product Types
      • 3.4.1 Heparin (Low Molecular Weight) Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Heparin (Low Molecular Weight) Product Type
      • 3.4.3 Date of International Manufacturers Enter into Heparin (Low Molecular Weight) Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Heparin (Low Molecular Weight) Sales by Product
    • 4.2 Global Heparin (Low Molecular Weight) Revenue by Product
    • 4.3 Heparin (Low Molecular Weight) Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Heparin (Low Molecular Weight) Breakdown Data by End User

    6 North America

    • 6.1 North America Heparin (Low Molecular Weight) by Countries
      • 6.1.1 North America Heparin (Low Molecular Weight) Sales by Countries
      • 6.1.2 North America Heparin (Low Molecular Weight) Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Heparin (Low Molecular Weight) by Product
    • 6.3 North America Heparin (Low Molecular Weight) by End User

    7 Europe

    • 7.1 Europe Heparin (Low Molecular Weight) by Countries
      • 7.1.1 Europe Heparin (Low Molecular Weight) Sales by Countries
      • 7.1.2 Europe Heparin (Low Molecular Weight) Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Heparin (Low Molecular Weight) by Product
    • 7.3 Europe Heparin (Low Molecular Weight) by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Heparin (Low Molecular Weight) by Countries
      • 8.1.1 Asia Pacific Heparin (Low Molecular Weight) Sales by Countries
      • 8.1.2 Asia Pacific Heparin (Low Molecular Weight) Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Heparin (Low Molecular Weight) by Product
    • 8.3 Asia Pacific Heparin (Low Molecular Weight) by End User

    9 Central & South America

    • 9.1 Central & South America Heparin (Low Molecular Weight) by Countries
      • 9.1.1 Central & South America Heparin (Low Molecular Weight) Sales by Countries
      • 9.1.2 Central & South America Heparin (Low Molecular Weight) Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Heparin (Low Molecular Weight) by Product
    • 9.3 Central & South America Heparin (Low Molecular Weight) by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Heparin (Low Molecular Weight) by Countries
      • 10.1.1 Middle East and Africa Heparin (Low Molecular Weight) Sales by Countries
      • 10.1.2 Middle East and Africa Heparin (Low Molecular Weight) Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Heparin (Low Molecular Weight) by Product
    • 10.3 Middle East and Africa Heparin (Low Molecular Weight) by End User

    11 Company Profiles

    • 11.1 Aspen
      • 11.1.1 Aspen Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Aspen Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Aspen Heparin (Low Molecular Weight) Products Offered
      • 11.1.5 Aspen Recent Development
    • 11.2 Sanofi-aventis
      • 11.2.1 Sanofi-aventis Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Sanofi-aventis Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Sanofi-aventis Heparin (Low Molecular Weight) Products Offered
      • 11.2.5 Sanofi-aventis Recent Development
    • 11.3 Pfizer
      • 11.3.1 Pfizer Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Pfizer Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Pfizer Heparin (Low Molecular Weight) Products Offered
      • 11.3.5 Pfizer Recent Development
    • 11.4 Opocrin
      • 11.4.1 Opocrin Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Opocrin Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Opocrin Heparin (Low Molecular Weight) Products Offered
      • 11.4.5 Opocrin Recent Development
    • 11.5 CSBIO
      • 11.5.1 CSBIO Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 CSBIO Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 CSBIO Heparin (Low Molecular Weight) Products Offered
      • 11.5.5 CSBIO Recent Development
    • 11.6 Dongying Tiandong Pharmaceutical
      • 11.6.1 Dongying Tiandong Pharmaceutical Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Products Offered
      • 11.6.5 Dongying Tiandong Pharmaceutical Recent Development
    • 11.7 Changzhou Qianhong Bio-pharma
      • 11.7.1 Changzhou Qianhong Bio-pharma Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Products Offered
      • 11.7.5 Changzhou Qianhong Bio-pharma Recent Development
    • 11.8 Techdow
      • 11.8.1 Techdow Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Techdow Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Techdow Heparin (Low Molecular Weight) Products Offered
      • 11.8.5 Techdow Recent Development
    • 11.9 Yantai Dongcheng Pharmaceutical Group
      • 11.9.1 Yantai Dongcheng Pharmaceutical Group Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Products Offered
      • 11.9.5 Yantai Dongcheng Pharmaceutical Group Recent Development

    12 Future Forecast

    • 12.1 Heparin (Low Molecular Weight) Market Forecast by Regions
      • 12.1.1 Global Heparin (Low Molecular Weight) Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Heparin (Low Molecular Weight) Revenue Forecast by Regions 2019-2025
    • 12.2 Heparin (Low Molecular Weight) Market Forecast by Product
      • 12.2.1 Global Heparin (Low Molecular Weight) Sales Forecast by Product 2019-2025
      • 12.2.2 Global Heparin (Low Molecular Weight) Revenue Forecast by Product 2019-2025
    • 12.3 Heparin (Low Molecular Weight) Market Forecast by End User
    • 12.4 North America Heparin (Low Molecular Weight) Forecast
    • 12.5 Europe Heparin (Low Molecular Weight) Forecast
    • 12.6 Asia Pacific Heparin (Low Molecular Weight) Forecast
    • 12.7 Central & South America Heparin (Low Molecular Weight) Forecast
    • 12.8 Middle East and Africa Heparin (Low Molecular Weight) Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Heparin (Low Molecular Weight) Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Heparin (Low Molecular Weight) market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Heparin (Low Molecular Weight) market based on company, product type, end user and key regions.

      This report studies the global market size of Heparin (Low Molecular Weight) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Heparin (Low Molecular Weight) in these regions.
      This research report categorizes the global Heparin (Low Molecular Weight) market by top players/brands, region, type and end user. This report also studies the global Heparin (Low Molecular Weight) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Aspen
      Sanofi-aventis
      Pfizer
      Opocrin
      CSBIO
      Dongying Tiandong Pharmaceutical
      Changzhou Qianhong Bio-pharma
      Techdow
      Yantai Dongcheng Pharmaceutical Group

      Market size by Product
      Enoxaparin
      Dalteparin
      Tinzaparin
      Fraxiparine
      Market size by End User
      Treatment of Venous Thromboembolism
      Complications of Pregnancy
      Cardioversion of Atrial Fibrillation/Flutter
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Heparin (Low Molecular Weight) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Heparin (Low Molecular Weight) market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Heparin (Low Molecular Weight) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Heparin (Low Molecular Weight) submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Heparin (Low Molecular Weight) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Heparin (Low Molecular Weight) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now